9 unchanged sentences
On May 6, 2022, Moderna filed a partial motion to dismiss the claims “relating to Moderna’s sale and provision of COVID-19 vaccine doses to the U.S.
−Removed: Government.” The motion is now fully briefed.
−Removed: No oral argument date has been set and no case schedule is yet in place.
+Added: Government.” On November 2, 2022, the Court issued an Order denying Moderna’s motion.
Acuitas Declaratory Judgment Lawsuit
4 unchanged sentences
Acuitas also seeks a declaration that each of the listed patents is invalid.
−Removed: On June 24, 2022, Arbutus and Genevant sought a pre-motion conference concerning their anticipated motion to dismiss all of Acuitas’ claims due to lack of subject matter jurisdiction.
−Removed: The request for a pre-motion conference was granted, but the case was subsequently re-assigned to a new judge who has not yet set a new pre-motion conference date.
+Added: On June 24, 2022, we and Genevant sought a pre-motion conference concerning our anticipated motion to dismiss all of Acuitas’ claims due to lack of subject matter jurisdiction.
+Added: The request for a pre-motion conference was granted, but the case was subsequently re-assigned to a new judge who entered an order directing:
+Added: (i) Acuitas to inform the court whether it intended to file an amended complaint;
+Added: (ii) that Acuitas must file any amended complaint by a certain date;
+Added: and (iii) that if Acuitas did not file an amended complaint, we and Genevant must file our motion to dismiss by a certain date.
+Added: Acuitas filed its amended complaint on September 6, 2022.
+Added: On October 4, 2022, we and Genevent filed our motion to dismiss the Acuitas action for lack of subject matter jurisdiction based on the lack of a case or controversy.
+Added: Acuitas filed its opposition to the motion to dismiss on November 1, 2022, and we and Genevant intend to file our reply brief on November 16, 2022.
No case schedule is yet in place.
8 unchanged sentences
Oral hearings for this matter were held in April 2022 and, on July 11, 2022, the arbitrator issued his decision fully dismissing UBC’s claim for royalties.
−Removed: As a result, no payments are owed to UBC and the Company intends to pursue an award for reimbursement of costs and attorneys’ fees.
+Added: As a result, no payments are owed to UBC.
+Added: In September 2022, the arbitrator awarded the Company $0.5 million for reimbursement of costs and attorneys’ fees, which the Company received from UBC in October 2022.
+Added: This matter is now fully resolved.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.